Literature DB >> 6699546

Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen.

G J Cianciolo, D Phipps, R Snyderman.   

Abstract

Virus-related oncogenes have been demonstrated in human tumor cells and may play a role in neoplastic transformation. Cancerous effusions contain inhibitors of monocyte function and are absorbed by monoclonal antibodies to the immunosuppressive retroviral structural protein, P15E. We therefore examined eight human malignant cell lines for P15E-related antigens, by indirect immunofluorescence. Up to 87% of fixed malignant cells were reactive with two different monoclonal anti-P15E antibodies, while under identical conditions approximately 7% of freshly isolated human mononuclear cells were positive. Differentiation of two tumor cell lines with dibutyryl cyclic AMP resulted in decreased anti-P15E reactivity. Blast transformation of human mononuclear cells with mitogens induced reactivity with anti-P15E. Thus human malignant and blast-transformed cells contain antigens related to P15E. Expression of this viral-related gene may occur during rapid cell division and be abnormally regulated in cancer cells, thus rendering them more resistant to immune destruction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699546      PMCID: PMC2187259          DOI: 10.1084/jem.159.3.964

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Inhibition of human lymphocyte mitogen and antigen response by a 15,000-dalton protein from feline leukemia virus.

Authors:  L C Hebebrand; R G Olsen; L E Mathes; W S Nichols
Journal:  Cancer Res       Date:  1979-02       Impact factor: 12.701

2.  Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses.

Authors:  G J Cianciolo; T J Matthews; D P Bolognesi; R Snyderman
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

3.  Monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants on the p 15(E) and gp70 envelope proteins.

Authors:  M E Lostrom; M R Stone; M Tam; W N Burnette; A Pinter; R C Nowinski
Journal:  Virology       Date:  1979-10-30       Impact factor: 3.616

4.  An inhibitor of macrophage chemotaxis produced by neoplasms.

Authors:  R Snyderman; M C Pike
Journal:  Science       Date:  1976-04-23       Impact factor: 47.728

5.  SV40-53K antigen: a possible role for 53K in normal cells.

Authors:  J Milner; S Milner
Journal:  Virology       Date:  1981-07-30       Impact factor: 3.616

6.  Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

Authors:  A B DeLeo; G Jay; E Appella; G C Dubois; L W Law; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

7.  Localization of the src gene product of the Harvey strain of MSV to plasma membrane of transformed cells by electron microscopic immunocytochemistry.

Authors:  M C Willingham; I Pastan; T Y Shih; E M Scolnick
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

8.  The mechanism of retrovirus suppression of human T cell proliferation in vitro.

Authors:  E A Copelan; J J Rinehart; M Lewis; L Mathes; R Olsen; A Sagone
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

9.  Depression of murine macrophage accumulation by low-molecular-weight derived from spontaneous mammary carcinomas.

Authors:  G J Cianciolo; R B Herberman; R Snyderman
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

10.  Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses.

Authors:  G Cianciolo; J Hunter; J Silva; J S Haskill; R Snyderman
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

View more
  25 in total

1.  Expression of envelope proteins of endogeneous C-type retrovirus on the surface of mouse and human oocytes at fertilization.

Authors:  B O Nilsson; M Jin; A C Andersson; P Sundström; E Larsson
Journal:  Virus Genes       Date:  1999       Impact factor: 2.332

Review 2.  Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

Authors:  R G Olsen; M G Lewis; L J Lafrado; L E Mathes; K Haffer; R Sharpee
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Role of antibodies to murine leukemia virus p15E transmembrane protein in immunotherapy against AKR leukemia: a model for studies in human acquired immunodeficiency syndrome.

Authors:  H J Thiel; H Schwarz; P Fischinger; D Bolognesi; W Schäfer
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

4.  Beneficial effects of the thymic hormone preparation thymostimulin in patients with defects in cell-mediated immunity and chronic purulent rhinosinusitis. A double-blind cross-over trial on improvements in monocyte polarization and clinical effects.

Authors:  M Tas; J A Leezenberg; H A Drexhage
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

5.  Abnormal monocyte chemotaxis in patients with chronic purulent rhinosinusitis: an effect of retroviral p15E-related factors in serum.

Authors:  E M van de Plassche-Boers; M Tas; M de Haan-Meulman; M Kleingeld; H A Drexhage
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

6.  Successful tumour immunotherapy: possible role of antibodies to anti-inflammatory factors produced by neoplasms.

Authors:  M Nelson; D S Nelson; P B Spradbrow; V K Kuchroo; P A Jennings; G J Cianciolo; R Snyderman
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

7.  Glucocorticoid-mediated immunomodulation: hydrocortisone enhances immunosuppressive endogenous retroviral protein (p15E) expression in mouse immune cells.

Authors:  M Fiegl; E Strasser-Wozak; S Geley; A Gsur; J Drach; R Kofler
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

8.  Impairment of polymorphonuclear leucocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome.

Authors:  A Lazzarin; C Uberti Foppa; M Galli; A Mantovani; G Poli; F Franzetti; R Nóvati
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

9.  Suppression of human lymphocyte mitogen response by retroviruses of type D. II. Non-activity of Mason-Pfizer monkey virus versus activity of human cell line derived virus PMFV.

Authors:  J Denner; L Indzhiia; V Wunderlich; G Sydow; D Bierwolf; B A Lapin
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

Review 10.  Effects of tumor growth on host defenses.

Authors:  G J Cianciolo; R Snyderman
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.